Information on Sotalol IV regimen presented at Alliance of Cardiovascular Professionals meeting

Rachael Durie, PharmD at AltaThera presented new data on AFIB dosing to the Alliance of Cardiovascular Professionals. She highlighted the clinical benefits of reduced length of hospital stay, especially relevant during COVID. In addition, she explained the hospital cost savings with the 1-day regimen recently approved by FDA.